Does Donating Plasma Lower Cholesterol?

Donating plasma does lower total cholesterol and LDL cholesterol in the short term, according to the best available research. A prospective multicentre study of regular plasma donors found statistically significant drops in both measures, with the largest reductions seen in people who started with high cholesterol and donated frequently. But the picture is more complicated than a simple yes, and the effect is not equivalent to medical cholesterol management in any meaningful way.

What the Largest Study Found

The most detailed look at this question comes from a prospective study across multiple donation centers that tracked cholesterol levels in voluntary plasma donors over time. Using a statistical model that accounted for sex, baseline cholesterol, and the interval between donations, the researchers found significant decreases in both total cholesterol and LDL cholesterol for men and women across all starting cholesterol levels. The biggest drops occurred in donors who had high baseline cholesterol and who donated frequently, with just two to four days between sessions. Women in that high-baseline, frequent-donation group saw the largest predicted decrease at roughly 47 mg/dL in total cholesterol, while men in the same category saw about a 32 mg/dL decrease.¹

For context, a drop of 30 to 47 mg/dL in total cholesterol is substantial. Many people taking statin medications see reductions in that range. But the study’s findings describe a modeled best-case scenario for the most responsive donors donating at near-maximum frequency, not the typical donor showing up once every couple of weeks.

The same study also found small but statistically significant increases in HDL cholesterol among donors who started with low HDL levels. That is a favorable direction, since HDL is the form of cholesterol associated with cardiovascular protection. Again, though, the increases were modest.¹

Why Plasma Donation Removes Cholesterol in the First Place

The mechanism is straightforward. Cholesterol travels through your bloodstream attached to lipoproteins, which are particles made of fat and protein. When a donation center draws your plasma, it pulls out the liquid portion of your blood, which contains those lipoproteins along with other dissolved substances. Your red blood cells are returned to you, but the cholesterol-carrying particles leave with the plasma. Your body then has to rebuild its plasma volume and resynthesize the proteins and lipids that were removed.

This is not the same as what a cholesterol-lowering drug does. Statins, for example, reduce how much cholesterol your liver produces in the first place. Plasma donation physically removes cholesterol that has already been made. Your liver responds by ramping up production to replace what was lost, which is why the cholesterol-lowering effect is temporary and closely tied to how often you donate.

Does the Effect Last?

The short answer is: only if you keep donating. The multicentre study’s model showed that the interval between donations mattered enormously. Donors who waited longer between sessions saw smaller cholesterol reductions, because the body has time to replenish its lipid levels between visits. The steepest drops were associated with the shortest donation intervals of two to four days.¹

In practical terms, most plasma donation centers in the United States allow donors to return twice within a seven-day period, with at least one day between sessions. That frequency roughly aligns with the window where the study observed meaningful cholesterol effects. But if you stop donating or switch to a less frequent schedule, your cholesterol levels will drift back toward their baseline. There is no evidence that a temporary course of plasma donation produces lasting improvements in your lipid profile after you stop.

Conflicting Signals From Other Research

Not all studies point in the same direction, and that matters. A multicenter prospective cohort study of plasma donors in China tracked lipid profiles from the first through the tenth donation and found a different pattern. In donors with asymptomatic high cholesterol, HDL cholesterol, total cholesterol, and apolipoprotein B all increased over the course of repeated donations, while triglycerides decreased.²

An increase in total cholesterol and apolipoprotein B runs counter to the earlier multicentre study’s findings. Several explanations are possible. The timing of blood draws relative to the most recent donation could differ between studies. The Chinese study tracked changes across ten sequential donations rather than modeling cholesterol as a function of the gap between any two visits. Dietary differences, genetic variation in lipid metabolism, and the specific apheresis equipment used could all play a role. The two studies also measured slightly different things: one modeled immediate post-donation levels, and the other tracked trends across a longer series.

What this means for you is that the cholesterol-lowering effect of plasma donation is real in the immediate aftermath of each session, but the longer-term trajectory of your lipid profile with repeated donation is less predictable. Your body’s compensatory response to losing plasma lipids may, over time, push certain cholesterol markers in unexpected directions.

Why Women May See Larger Drops

The multicentre study’s model predicted noticeably larger cholesterol decreases in women than in men. At high baseline cholesterol with frequent donations, the predicted total cholesterol drop for women was about 47 mg/dL compared to about 32 mg/dL for men.¹ The study did not explore the biological reasons for this gap in depth, but sex-based differences in lipid metabolism are well established. Women tend to have different distributions of lipoprotein subtypes and different rates of hepatic cholesterol synthesis than men, and hormonal factors influence how quickly the liver replaces removed cholesterol. Whatever the mechanism, the data suggest that the magnitude of the cholesterol reduction from plasma donation is not the same for everyone and that sex is one factor driving the variation.

Voluntary Donation Versus Therapeutic Plasma Exchange

There is an important distinction between walking into a donation center for a routine plasma donation and undergoing therapeutic plasma exchange prescribed by a physician. Therapeutic apheresis has been used since the 1970s for patients with conditions like familial hypercholesterolemia, where LDL levels are dangerously high due to genetic factors and standard medications are insufficient. In these patients, specialized lipoprotein apheresis selectively removes LDL particles from the blood and has been shown to reduce cardiovascular events.³

That is a very different procedure from voluntary plasmapheresis at a commercial donation center. Lipoprotein apheresis targets specific particles, uses specialized filtration columns, and is performed under medical supervision with the explicit goal of reducing cardiovascular risk. Voluntary plasma donation removes bulk plasma without selectivity. While both procedures happen to lower cholesterol, they are not interchangeable. Researchers have explored whether lower-volume plasma exchange might have therapeutic benefits for various conditions including metabolic diseases, but the clinical evidence for this remains limited.⁴

If you have been diagnosed with high cholesterol, plasma donation is not a substitute for medical treatment. Statins, PCSK9 inhibitors, dietary changes, and exercise all have robust clinical evidence supporting their long-term effects on cardiovascular risk. Plasma donation’s cholesterol-lowering effect, while measurable, has never been studied as a cardiovascular intervention, and no clinical guidelines recommend it for that purpose.

The Trade-Offs of Frequent Donation

Frequent plasma donation carries costs that go well beyond cholesterol. Your plasma contains immunoglobulins, albumin, and other proteins that your body needs for immune function and fluid balance. Donating often depletes these proteins, and your body may not fully replace them between sessions.

A randomized controlled trial comparing different donation frequencies found that donors who gave plasma three times every two weeks saw their immunoglobulin G (IgG) levels fall significantly. About a quarter of those high-frequency donors dropped below the IgG threshold of 6.0 g/L, even though most started with levels above 8.0 g/L.⁵ IgG is a critical antibody, and levels that low could leave you more vulnerable to infections.

Another randomized trial found that very high frequency donors experienced drops in albumin, IgG, IgA, and IgM that persisted beyond the donation period. Even at somewhat lower donation frequencies, IgG and IgM remained depressed weeks after the last session.⁶ So if you are donating plasma at the high frequency that produces the most cholesterol reduction, you are also donating at the frequency most likely to impair your immune defenses. That is a trade-off no one should make in pursuit of a cholesterol number.

Effects on Blood Flow and Vascular Function

Plasma donation also has short-term effects on your cardiovascular system that go beyond lipid levels. A study that measured blood properties before and after donation found that donating plasma increased whole blood viscosity by about 8% immediately afterward, because removing the liquid fraction of blood concentrates the remaining red blood cells. Despite this thickening, the researchers found no change in shear stress or blood flow through larger arteries.⁷

More interestingly, plasma donation lowered systolic blood pressure and enhanced microvascular reactivity, meaning that the tiny blood vessels in tissues responded more vigorously to changes in blood flow. Red blood cell deformability, which is how easily red cells squeeze through narrow capillaries, was temporarily impaired right after donation but recovered within 24 hours. Red blood cell aggregation, a factor that influences how smoothly blood flows, actually decreased by the next day.⁷

These findings are physiologically interesting but do not amount to a cardiovascular benefit you should bank on. The blood pressure drop is transient, the viscosity increase is temporary, and no one has followed donors long enough to know whether repeated cycles of these short-term changes add up to better or worse vascular health over years.

An Unexpected Benefit Worth Knowing About

One genuinely useful secondary effect of plasma donation has nothing to do with cholesterol. A randomized clinical trial of Australian firefighters, who tend to have elevated levels of per- and polyfluoroalkyl substances (PFAS, often called “forever chemicals”) from firefighting foam exposure, tested whether regular blood or plasma donation could reduce those levels.

Over 52 weeks, firefighters in the plasma donation group saw their PFOS levels drop by about 2.9 ng/mL on average, compared to essentially no change in the observation-only group. Plasma donation was also more effective than whole blood donation, which reduced PFOS by about 1.1 ng/mL. For another PFAS compound called PFHxS, plasma donation reduced levels by about 1.1 ng/mL while neither blood donation nor observation produced a significant change.⁸

PFAS compounds bind to proteins in plasma and are notoriously difficult for the body to eliminate on its own. Physically removing plasma and the PFAS bound to it turns out to be one of the few demonstrated ways to accelerate clearance. This is relevant well beyond firefighters: PFAS contamination of drinking water affects communities worldwide, and some people have elevated levels without knowing it. For those individuals, regular plasma donation might serve a purpose that has nothing to do with lipid panels.

When to Take Cholesterol Management Seriously

The fact that plasma donation lowers cholesterol in the short term is scientifically interesting but practically limited. If your doctor has flagged your cholesterol as a concern, the evidence-based path forward involves lifestyle modifications and, when appropriate, medication. The cholesterol reduction from plasma donation requires a grueling schedule of near-daily visits, the effect vanishes when you stop, the reductions are unpredictable from person to person, and the immune costs of frequent donation are real.

Where the research does have practical value is in reassuring regular plasma donors that their cholesterol levels measured shortly after a donation may read lower than their true baseline. If you donate plasma regularly and your doctor orders a lipid panel, mention your donation schedule. A blood draw taken a day after plasma donation could show artificially low LDL, which might mask a lipid problem that actually needs attention. Conversely, some donors may see lipid markers shift in unexpected directions over a longer series of donations, as the Chinese cohort study suggested. Either way, your doctor needs the full picture to interpret the numbers correctly.